Evidence map›Paper›PMID 42702940›Full record

Observational studyRisk analysis : an official publication of the Society for Risk Analysis2026

Acceptance of the COVID-19 Booster Vaccine Amid the Omicron JN.1 Surge in Southern Bangladesh: A Comparative Analysis of Rural-Urban Disparities.

Debendra Nath Roy, Shaheb Ali, Asma Aktar, Md Ekramul Islam, Md Shah Azam

Abstract readComparative StudyObservational Study
In one paragraph

Observational study in Risk analysis : an official publication of the Society for Risk Analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Debendra Nath RoyDepartment of Pharmacy, Jashore University of Science and Technology, Jashore, Bangladesh.ORCID https://orcid.org/0000-0001-8622-0108
Shaheb AliDepartment of Pharmacy, Jashore University of Science and Technology, Jashore, Bangladesh.
Asma AktarDepartment of Pharmacy, Jashore University of Science and Technology, Jashore, Bangladesh.ORCID https://orcid.org/0009-0005-6087-1611
Md Ekramul IslamDepartment of Pharmacy, University of Rajshahi, Rajshahi, Bangladesh.ORCID https://orcid.org/0000-0003-4664-3709
Md Shah AzamDepartment of Marketing, University of Rajshahi, Rajshahi, Bangladesh.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rapid spread of SARS-CoV-2 variants, including Omicron JN.1, has revived significant challenges to health systems and regenerates microbial risk to public health security. Although COVID-19 booster vaccines have ensured enhanced protection against new variants, there remain persistent disparities in vaccine acceptance and uptake between rural and urban populations. This study assesses COVID-19 booster vaccine acceptance and compares antecedents of acceptance across rural and urban communities in Southern Bangladesh. A cross-sectional observational study was conducted between December 15, 2023, and March 15, 2024, in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. By using stratified random sampling, 707 adults comprising 379 rural and 328 urban respondents (refusal rate: 16.7% rural, 23.2% urban) were surveyed. The study employed descriptive statistics and binary logistic regression analysis to identify socio-psychological predictors of booster acceptance, with statistical significance set at p < 0.05. The acceptance rate of COVID-19 vaccine booster dose was 69.9% overall, with a significantly lower rate in rural 62.5% (95% CI: 60.6-64.8) compared to urban areas 78.4% (95% CI: 76.2-80.6, χ

Indexed as

COVID-19COVID-19 VaccinesImmunization, SecondaryPatient Acceptance of Health CareRural PopulationUrban PopulationAdolescentAdultBangladeshCross-Sectional StudiesFemaleHumansMaleMiddle AgedSARS-CoV-2Young AdultCOVID-19 VaccinesBangladeshCOVID‐19Omicron JN.1rural–urbanvaccine booster

Identifiers

PMID42702940
PMCPMC13547763

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.